Recent studies have reported that reduction of leucine levels inhibited proliferation of ER+ (breast cancers that express estrogen receptors) breast cancer cells, whereas increased leucine levels enhanced proliferation of ER+ breast cancer cells. The gene discussed is ESR1; the disease is breast carcinoma.